MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/1471-0528.13032

Медицинская библиотека · BJOG : an international journal of obstetrics and gynaecology · 2014

Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.

Schuit E, Stock S, Rode L, Rouse D J, Lim A C, Norman J E, Nassar A H, Serra V, Combs C A, Vayssiere C, Aboulghar M M, Wood S, Çetingöz E, Briery C M, Fonseca E B, Worda K, Tabor A, Thom E A, Caritis S N, Awwad J, Usta I M, Perales A, Meseguer J, Maurel K, Garite T, Aboulghar M A, Amin Y M, Ross S, Cam C, Karateke A, Morrison J C, Magann E F, Nicolaides K H, Zuithoff N P A, Groenwold R H H, Moons K G M, Kwee A, Mol B W J, Global Obstetrics Network (GONet) collaboration

СтатьяМетаанализПоддержка исследования: вне правительства СШАОбзорПеревод в очереди

Аннотация

BACKGROUND

In twin pregnancies, the rates of adverse perinatal outcome and subsequent long-term morbidity are substantial, and mainly result from preterm birth (PTB).

OBJECTIVES

To assess the effectiveness of progestogen treatment in the prevention of neonatal morbidity or PTB in twin pregnancies using individual participant data meta-analysis (IPDMA).

SEARCH STRATEGY: We searched international scientific databases, trial registration websites, and references of identified articles.

SELECTION CRITERIA: Randomised clinical trials (RCTs) of 17-hydroxyprogesterone caproate (17Pc) or vaginally administered natural progesterone, compared with placebo or no treatment.

DATA COLLECTION AND ANALYSIS: Investigators of identified RCTs were asked to share their IPD. The primary outcome was a composite of perinatal mortality and severe neonatal morbidity. Prespecified subgroup analyses were performed for chorionicity, cervical length, and prior spontaneous PTB.

MAIN

RESULTS

Thirteen trials included 3768 women and their 7536 babies. Neither 17Pc nor vaginal progesterone reduced the incidence of adverse perinatal outcome (17Pc relative risk, RR 1.1; 95% confidence interval, 95% CI 0.97-1.4, vaginal progesterone RR 0.97; 95% CI 0.77-1.2). In a subgroup of women with a cervical length of ≤25 mm, vaginal progesterone reduced adverse perinatal outcome when cervical length was measured at randomisation (15/56 versus 22/60; RR 0.57; 95% CI 0.47-0.70) or before 24 weeks of gestation (14/52 versus 21/56; RR 0.56; 95% CI 0.42-0.75).

AUTHOR'S

CONCLUSIONS

In unselected women with an uncomplicated twin gestation, treatment with progestogens (intramuscular 17Pc or vaginal natural progesterone) does not improve perinatal outcome. Vaginal progesterone may be effective in the reduction of adverse perinatal outcome in women with a cervical length of ≤25 mm; however, further research is warranted to confirm this finding.

Для цитирования: Schuit E, Stock S, Rode L, Rouse D J, Lim A C, Norman J E, Nassar A H, Serra V, Combs C A, Vayssiere C, Aboulghar M M, Wood S, Çetingöz E, Briery C M, Fonseca E B, Worda K, Tabor A, Thom E A, Caritis S N, Awwad J, Usta I M, Perales A, Meseguer J, Maurel K, Garite T, Aboulghar M A, Amin Y M, Ross S, Cam C, Karateke A, Morrison J C, Magann E F, Nicolaides K H, Zuithoff N P A, Groenwold R H H, Moons K G M, Kwee A, Mol B W J, Global Obstetrics Network (GONet) collaboration. Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.. BJOG : an international journal of obstetrics and gynaecology. 2014. DOI: 10.1111/1471-0528.13032.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.